Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

Amit LangoteSwapnil HiremathMarcel RuzickaBrendan B McCormick

Published in: PloS one (2017)

Spironolactone is safe and effective in treating hypokalemia in PD patients. It is also an effective antihypertensive agent and merits further study in the PD population.

Keyphrases

end stage renal disease
peritoneal dialysis
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors